Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Tomoshi Ohya is active.

Publication


Featured researches published by Tomoshi Ohya.


Journal of Bioscience and Bioengineering | 2000

High-level expression of recombinant human serum albumin from the methylotrophic yeast Pichia pastoris with minimal protease production and activation

Kaoru Kobayashi; Shinobu Kuwae; Tomoshi Ohya; Toyoo Ohda; Masao Ohyama; Hideyuki Ohi; Kenji Tomomitsu; Takao Ohmura

The methylotrophic yeast, Pichia pastoris, is widely used as a host strain for the production of a variety of heterologous proteins. We used P. pastoris for the production of recombinant human serum albumin (rHSA). In several runs of fed-batch fermentation, rapid degradation of rHSA was observed, coinciding with a sudden increase of protease activity in the culture broth. Monitoring the changes in the concentration of the medium components during fermentation suggested that this phenomenon was caused by nitrogen starvation. Increased initial concentrations of ammonia and phosphoric acid in the medium prevented the protease production during fermentation. Using this improved medium, stable production of rHSA of around 1.4 g/l was achieved. Although protease activity in the culture broth of the improved medium was not detected by the casein plate method at the end of fermentation, potential protease activity remained and could be activated by decreasing the pH of the culture broth, a high degradation rate of 660 mg HSA/l/h was observed at pH 4.3, but degradation did not occur above pH 5.9.


Journal of Bioscience and Bioengineering | 2000

High Level Secretion of Recombinant Human Serum Albumin by Fed-Batch Fermentation of the Methylotrophic Yeast, Pichia pastoris, Based on Optimal Methanol Feeding Strategy.

Kaoru Kobayashi; Shinobu Kuwae; Tomoshi Ohya; Toyoo Ohda; Masao Ohyama; Kenji Tomomitsu

The dynamic programming method was applied to obtain the optimal specific growth rate, mu, in the fed-batch fermentation using the recombinant human serum albumin (rHSA)-producing yeast, Pichia pastoris. Based on the relationship between the specific production rate, varrho, and the specific growth rate, mu, a simple mathematical model describing the growth and rHSA production was constructed and used for calculations. Two constraints, final volume and maximum methanol feed rate, were adopted for calculations and the optimal mu resulted as follows. That is, mu was initially at the maximum value, mu(max), then decreased gradually. Finally, mu decreased to the mu(min) that gave a maximum varrho. The decline of mu was revealed to be caused by the constraint for maximum methanol feeding rate, F(max), and F(max) was constant until mu decreased to mu(min). We tried to realize the optimal mu in the fed-batch fermentation by manipulating the methanol feeding rate and obtained it. However, the observed varrho was differed from the expected one. The discrepancy between the expected varrho and observed varrho after the change of mu suggests the inapplicability of the relationship between mu and varrho to dynamic situations where mu changes. To confirm this, simulation and fed-batch fermentation runs were carried out at a methanol feeding rate that would cause a continuous change in mu. The rHSA production was simulated well, suggesting the applicability of the relationship between mu and varrho in such situations. Discontinuity in the change in methanol feeding rate of the optimal feed pattern at the time mu changed is considered to be the cause for the discrepancy between the expected and observed varrho. Therefore, a new methanol feeding strategy that could mimic the changes in mu and varrho of the optimal strategy without a discontinuity in the feeding rate was sought using a mathematical model of fermentation by trial and error. This modification in the methanol feeding rate resulted in a considerably improved varrho and 18% increase in total rHSA production compared with those obtained by the optimal strategy.


Journal of Bioscience and Bioengineering | 2008

Overexpression of GADD34 Enhances Production of Recombinant Human Antithrombin III in Chinese Hamster Ovary Cells

Takeshi Omasa; Takashi Takami; Tomoshi Ohya; Eriko Kiyama; Tetsuji Hayashi; Hiroko Nishii; Hideo Miki; Kaoru Kobayashi; Kohsuke Honda; Hisao Ohtake

To improve the production of recombinant human antithrombin III (AT-III) in Chinese hamster ovary (CHO) cells, the gene encoding growth arrest and DNA damage inducible protein 34 (GADD34), which is a transcription factor involved in the unfolded protein response (UPR), was cloned from CHO-K1 cells. Overexpression of GADD34 significantly enhanced the production of recombinant AT-III in CHO 13D-35D cells. The specific rate of AT-III production in the GADD34-overexpressing CHO 13D-35D cells reached approximately 28 pg/cell/d. After 144 h of incubation, the AT-III concentration in the culture supernatant was approximately 40% higher than that observed in the case of the parental CHO 13D-35D cells. The mRNA expression, specific activity, and fucosylation of AT-III were not affected by GADD34 overexpression. Overexpression of GADD34 is a promising method of improving the production of secreted protein pharmaceuticals in CHO cells.


Journal of Bioscience and Bioengineering | 2000

Addition of oleic acid increases expression of recombinant human serum albumin by the AOX2 promoter in Pichia pastoris

Kaoru Kobayashi; Shinobu Kuwae; Tomoshi Ohya; Toyoo Ohda; Masao Ohyama; Kenji Tomomitsu

The addition of several kinds of fatty acid to the culture medium of a recombinant human serum albumin (rHSA)-producing yeast, Pichia pastoris, resulted in increased expression levels of the product. Among the fatty acids tested, a small amount of oleic acid (0.01% (w/v)) doubled the rHSA production level in a shake-flask culture when measured by the reversed passive hemagglutination assay method. To elucidate this phenomenon, studies were conducted using deletion mutants from the AOX2 promoter region. Deletion mutants, designed for a detailed evaluation of the methanol regulation elements (AOX2-UAS, AOX2-URS1, and AOX2-URS2) did not respond to the addition of oleic acid. However, a deletion mutant that was not lacking an upstream region from the AOX2 promoter showed a response to oleic acid. The results implied the presence of an oleic acid-responsive element between nucleotides (nt) -1529 and -803, and it may lie between nt -1411 and -1403 in the AOX2 promoter of P. pastoris. The response to oleic acid was shown to function even when the level of rHSA expression was increased by a mutation in the AOX2 promoter. Therefore addition of oleic acid to the medium is likely to play an important role, in cooperation with gene manipulation, in achieving high expression levels of rHSA for the purpose of commercial production.


Journal of Bioscience and Bioengineering | 2002

High-level production of prourokinase-annexin V chimeras in the methylotrophic yeast Pichia pastoris.

Tomoshi Ohya; Masanori Morita; Masami Miura; Shinobu Kuwae; Kaoru Kobayashi

Prourokinase (proUK)-annexin V chimeras expressed by the methylotrophic yeast Pichia pastoris in a synthetic medium as part of a system designed to yield a novel thrombolytic agent are degraded, as it is thought, by various yeast proteases present in the culture supernatant. Minimization of proteolysis was therefore investigated to increase the yield of intact proUK-annexin V. Protease inhibitor screening study indicated several proteases including at least serine protease like chymotrypsin were involved in the proteolysis. Addition of more than 10% of peptone or more than 0.2 mol l(-1) of arginine to the medium was effective in minimizing proteolysis in shake-flask culture. Culture condition of higher pH was also effective, however, induced a cell death. Cell improvement by increasing the methanol utilization ability yielded greater tolerance to high pH. As a result, the culture condition with highly concentrated peptone solution fed under controlled conditions of pH 8.0 was established, which greatly reduced proteolytic degradation in fed-batch fermentation. These optimal conditions, which enabled fibrinolytic activity to reach 7800 IU ml(-1), could easily be applied in industrial scale production.


Cytotechnology | 2013

Improved antibody production in Chinese hamster ovary cells by ATF4 overexpression

Ahmad M. Haredy; Akitoshi Nishizawa; Kohsuke Honda; Tomoshi Ohya; Hisao Ohtake; Takeshi Omasa

To improve antibody production in Chinese hamster ovary (CHO) cells, the humanized antibody-producing CHO DP-12-SF cell line was transfected with the gene encoding activating transcription factor 4 (ATF4), a central factor in the unfolded protein response. Overexpression of ATF4 significantly enhanced the production of antibody in the CHO DP-12-SF cell line. The specific IgG production rate of in the ATF4-overexpressing CHO-ATF4-16 cells was approximately 2.4 times that of the parental host cell line. Clone CHO-ATF4-16 did not show any change in growth rate compared with the parental cells or mock-transfected CHO-DP12-SF cells. The expression levels of mRNAs encoding both the antibody heavy and light chains in the CHO-ATF4-16 clone were analyzed. This analysis showed that ATF4 overexpression improved the total production and specific production rate of antibody without affecting the mRNA transcription level. These results indicate that ATF4 overexpression is a promising method for improving recombinant IgG production in CHO cells.


BMC Proceedings | 2011

ATF4 over-expression increased IgG1 productivity in Chinese hamster ovary cells.

Ahmad M. Haredy; Akitoshi Nishizawa; Kohsuke Honda; Tomoshi Ohya; Hisao Ohtake; Takeshi Omasa

The endoplasmic reticulum (ER) is the major organelle of synthesis of protein and forms a membranous network throughout the cell. According to Shimizu and Hendershot [1], about one third of the total proteins produced are synthesized in the ER. The ER lumen possesses a unique environment for high quality control for protein folding and assembly. It contains high concentrations of molecular chaperones, folding enzymes, and ATP, which aid in proper maturation of proteins [2]. However, if the amount of proteins to be folded exceeds the capacity of the folding machineries, unfolded proteins will accumulate in the ER and Unfolded protein response (UPR) will start. UPR aims at regaining the homeostasis inside the ER by attenuating the protein translation, activating the folding machineries, degradation of the unfolded proteins, and finally apoptosis. Activating transcription factor 4 (ATF4) is a central factor in the UPR pathways which is involved in folding and processing of secretory proteins. Our previous research showed that ATF4 over-expression is efficient for increasing the productivity of antithrombin-III [3,4]. In this study, we investigated if this approach is product-specific or not.


Biotechnology and Bioengineering | 2008

Improved production of recombinant human antithrombin III in Chinese hamster ovary cells by ATF4 overexpression.

Tomoshi Ohya; Tetsuji Hayashi; Eriko Kiyama; Hiroko Nishii; Hideo Miki; Kaoru Kobayashi; Kohsuke Honda; Takeshi Omasa; Hisao Ohtake


Biotechnology and Bioengineering | 2005

Optimization of human serum albumin production in methylotrophic yeast Pichia pastoris by repeated fed‐batch fermentation

Tomoshi Ohya; Masao Ohyama; Kaoru Kobayashi


Journal of Bioscience and Bioengineering | 2005

Production of recombinant human antithrombin by Pichia pastoris

Shinobu Kuwae; Masao Ohyama; Tomoshi Ohya; Hideyuki Ohi; Kaoru Kobayashi

Collaboration


Dive into the Tomoshi Ohya's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge